Friedman Steven M. 4
4 · INCYTE CORP · Filed Jan 25, 2010
Insider Transaction Report
Form 4
INCYTE CORPINCY
Friedman Steven M.
EVP, Biology & Preclinical Dev
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2010-01-21+72,700→ 72,700 totalExercise: $9.41Exp: 2017-01-20→ Common Stock (72,700 underlying) - Award
Incentive Stock Option (right to buy)
2010-01-21+12,300→ 12,300 totalExercise: $9.41Exp: 2017-01-20→ Common Stock (12,300 underlying)
Footnotes (1)
- [F1]Option begins vesting on grant date in 25 installments, the first 33.33% vesting on the one year anniversary of the grant date and the remaining 66.67% vesting in equal monthly installments during the two year period thereafter. Vesting may be accelerated and exercise term may be extended upon occurence of certain events.